Literature DB >> 11327233

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.

.   

Abstract

These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11327233     DOI： 10.1081/clt-100102886

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN： 0731-3810


  3 in total

1.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Emergency response to an anthrax attack.

Authors:  Lawrence M Wein; David L Craft; Edward H Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

3.  Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.

Authors:  Sherry R Crowe; Lori Garman; Renata J M Engler; A Darise Farris; Jimmy D Ballard; John B Harley; Judith A James
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.